Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Bourg En Bresse – page 3

30 clinical trials in Bourg En Bresse, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Bourg En Bresse at a glance
30
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

30 trials in Bourg En Bresse

Open in trial search

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Plasma cell myeloma

Not recruiting

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Breast cancer+2

Not recruiting

Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Unicancer

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Bourg En Bresse

What the registry says about research in the country

01 Oncology - Multiple Myeloma

Innovative research examining multiple myeloma treatments, including studies of elranatamab-lenalidomide combinations and evaluation of daratumumab therapies. Investigations focus on optimizing treatment duration and improving patient outcomes.

  • Treatment optimization studies
  • Therapy duration assessment
  • Novel drug combinations

Several trials are exploring personalized approaches for both newly diagnosed and relapsed cases.

02 Breast Cancer Research

Comprehensive studies focusing on breast cancer treatments, particularly in HER2-negative and hormone-receptor-positive cases. Research includes innovative approaches to hormone therapy and targeted treatments.

  • Metastatic breast cancer therapies
  • Hormone therapy optimization
  • Treatment de-escalation strategies

Trials aim to personalize treatment approaches and improve long-term outcomes.

03 Critical Care Medicine

Important studies in intensive care focusing on respiratory support and sepsis management. Research includes evaluation of high-flow nasal oxygen therapy protocols and corticosteroid treatments.

  • Respiratory support optimization
  • Sepsis treatment protocols
  • Patient weaning strategies

These trials aim to improve critical care outcomes and standardize treatment approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.